Clinical Trials Insight: 700028280
Latest Information Update: 08 Nov 2007
Price :
$35 *
At a glance
- Drugs Pralatrexate (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Allos Therapeutics
- 08 Nov 2007 New trial record.